ie
Introducing TwitchView2, a complete redesign based on experience in over 1,000,000 clinical cases around the world.
TwitchView2, manufactured by Blink, is distributed exclusively by Fannin in the UK, is a next-generation quantitative neuromuscular monitor engineered to endure the rigours of the operating theatre and deliver reliable performance even in the most challenging patients.
With a faster start-up, all clinically relevant data presented clearly on a single main display, and a streamlined workflow where the anaesthetist simply places the electrode and presses START — we’ve created the ultimate “EASY button”.
Performance Validation: TwitchView EMG is validated as accurate and interchangeable with mechanomyography (MMG) in top-tier publications.4, 5
Clinical Validation: TwitchView use has been proven to eliminate residual paralysis and change the management of NMB drugs, enhancing patient safety and reducing unnecessary hospital expenses.1
User Interaction: Attach the electrode and press play to start monitoring… that’s it.
Automatic Monitoring: Patented AutoPTCTM mode automatically switches between TOF and PTC measurements.
EMR Connectivity: Eliminates manual charting in Epic, Cerner, Innovian & more. We support an open interface commitment meaning we will connect to any EMR.
System Construction: Ruggedized monitor case and cable with a hospital-grade power cord.
Universal Mount: Proprietary mounting arm with flexible configurations to support any OR setup.
EMG Measurement Technique: Performs a comprehensive waveform analysis over thousands of data points, integrating the area under the curve (AUC) of the compound action potential alongside detection of multiple EMG signal features, to precisely identify even the smallest muscle twitches.
Noise Cancellation: Isolates the patient signal, capturing waveforms as small as 0.2 mV enabling reliable performance during deep block and in difficult-to-monitor patients like neonates.
Three electrode sizes: Large, Medium and Small, a neonate-specific electrode for infants <10kg.
All sizes are designed with a minimal footprint for placement alongside lines and other sensors.
In a landmark study, Thilen et al. investigated the impact of a protocol using TwitchView to manage rocuronium blockade and reversal.
Commenting on study results first author Dr. Thilen remarked, “Using an EMG-based quantitative neuromuscular monitor [TwitchView] and a decision support guide, we achieved an unprecedented 0% incidence rate of residual neuromuscular blockade while using sugammadex for less than 50% of all patients. Approximately 20% of the patients in our mixed surgical population achieved adequate spontaneous recovery and did not need any pharmacological reversal [2]”.
With TwitchView guiding intraoperative management and reversal of neuromuscular blockade, residual paralysis was prevented, and reversal drug costs were 70% lower than universal utilization of sugammadex[1].
For a more in-depth review of Dr. Thilen’s study, visit: : How to Implement the ASA Practice Guidelines for Neuromuscular Blockade
In a groundbreaking study, Bowdle et al. used TwitchView to test the effectivity of titrated doses of sugammadex after cardiac surgery. Investigators hypothesized that many patients could be reversed with less than the label recommended dose of sugammadex and that some patients would require more to achieve adequate recovery.
In an accompanying editorial [6], Todd and Kopman comment:
We believe that this constitutes some of the strongest evidence to date for the value of routine quantitative neuromuscular blockade monitoring— and clearly demonstrates the fallacy of believing that sugammadex obviates the need for such monitoring.
For more details on the potential impact of TwitchView on block antagonism, read: How Quantitative Train of Four Impacts Rocuronium Reversal
TwitchView2—manufactured by Blink—is available in the UK through Fannin!
Contact our team for more information or to schedule a product demonstration.
